Skip to main content
Top
Published in: Dermatology and Therapy 5/2024

Open Access 09-05-2024 | Basalioma | Case Series

Cutaneous Superficial Basal Cell Carcinoma is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas

Authors: Harsimran Kaur, Karen L. de Mesy Bentley, Syed Minhaj Rahman, Philip R. Cohen, Bruce R. Smoller

Published in: Dermatology and Therapy | Issue 5/2024

Login to get access

Abstract

Basal cell carcinoma (BCC) is the most common skin cancer. Skin cancers may present either as a non-invasive tumor or an invasive malignancy. The terminology of carcinoma in situ is used when the tumor is either just limited to epidermis or not present as single cells or nests in the dermis. However, currently the terminology superficial BCC is inappropriately used instead of BCC in situ when the skin cancer is limited to epidermis. In this study we compare the pathologic changes of superficial, nodular, and infiltrative BCCs using electron microscopy to identify the ultrastructural characteristics and validate the previously proposed terminology. Three cases of BCC (superficial BCC, nodular BCC, and infiltrative BCC) diagnosed by dermatopathologists at our institute were selected for review. Paraffin block tissues from these cases were sent for electron microscopy studies which demonstrated disruption of basal lamina in both nodular and infiltrative type of BCC, while it remains intact in BCC superficial type after extensive examination. Therefore, similar to other in situ skin cancers, there is no invasion of the neoplasm in superficial BCC into the dermis. Hence, the older term superficial BCC should be appropriately replaced with the newer terminology BCC in situ.
Literature
4.
go back to reference Nestor MS, Zarraga MB. The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol. 2012;5(4):20–4.PubMedPubMedCentral Nestor MS, Zarraga MB. The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol. 2012;5(4):20–4.PubMedPubMedCentral
11.
go back to reference Cohen PR. Superficial basal cell carcinoma of the skin is a cutaneous basal cell carcinoma in situ. SKINmed. In press. Cohen PR. Superficial basal cell carcinoma of the skin is a cutaneous basal cell carcinoma in situ. SKINmed. In press.
14.
go back to reference Rosai J. Basal cell carcinoma with follicular differentiation. Am J Dermatopathol. 1989;11(5):479–97.CrossRefPubMed Rosai J. Basal cell carcinoma with follicular differentiation. Am J Dermatopathol. 1989;11(5):479–97.CrossRefPubMed
15.
go back to reference Ackerman AB, de Viragh PA, Chongchitnant N, Reddy V, di Leonardo M. Basal cell carcinoma with follicular differentiation (Chapter 26). In: Ackerman’s histologic diagnosis of neoplastic skin diseases: a method by pattern analysis. Neoplasms with follicular differentiation. Philadelphia: Lea & Febiger; 1993. p. 605–58. https://doi.org/10.1097/00000372-198712000-00002.CrossRef Ackerman AB, de Viragh PA, Chongchitnant N, Reddy V, di Leonardo M. Basal cell carcinoma with follicular differentiation (Chapter 26). In: Ackerman’s histologic diagnosis of neoplastic skin diseases: a method by pattern analysis. Neoplasms with follicular differentiation. Philadelphia: Lea & Febiger; 1993. p. 605–58. https://​doi.​org/​10.​1097/​00000372-198712000-00002.CrossRef
17.
Metadata
Title
Cutaneous Superficial Basal Cell Carcinoma is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas
Authors
Harsimran Kaur
Karen L. de Mesy Bentley
Syed Minhaj Rahman
Philip R. Cohen
Bruce R. Smoller
Publication date
09-05-2024
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 5/2024
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-024-01151-x

Other articles of this Issue 5/2024

Dermatology and Therapy 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.